Maisha Maliha, MD, a medical resident at NYC Health + Hospitals/Jacobi in the Morris Park section of The Bronx, won the top prize at PAGNY’s 9th Annual Research Day on Wednesday, Nov. 13.
An international team of researchers has uncovered evidence of partial resistance to artemisinin derivatives -- the primary treatment for malaria -- in young children with severe malaria.
A ground-breaking study reveals that artemisinin, a key malaria treatment, is showing alarming signs of partial resistance ...
A family in Jaipur faces tragedy as a father and his two children test positive for malaria; three of his other children ...
10 patients who were thought to have been cured suffered a repeat malaria attack within 28 days from the same strain of ...
A new study from Uganda provides the first evidence to date that resistance to a lifesaving malaria drug may be emerging in ...
Scientists have warned that the fight against malaria in Africa may have got tougher after a new study found that a ...
malaria with signs of severe disease caused by the malaria parasite Plasmodium falciparum. Also, 10 patients who were thought ...
Over 600,000 people worldwide die from mosquito-borne malaria each year, with the majority of these deaths happening among ...
The 10.3% of participants that experienced recrudescence -- recurrent malaria caused by the same strain of P. falciparum as ...
A study conducted in Uganda has found evidence of partial resistance to the primary treatment for malaria in young children ...
The malaria parasite may be gaining resistance against artemisinin, the drug most often used to try and save children with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback